Taylor Boswell
Analyst · KBW. Your line is now open
Thank you, Linda, and thanks to everyone on the call this morning for their interest in and support of CGBD. As usual, I’ll start by briefly sharing an update on Carlyle’s current read of economic and credit market conditions. I will spend most of my time on the topic of credit performance and the reasons why we expect it to improve in the coming quarters as compared to the experience of 2019. On the economic front, at the time of our last report there was concern, which Carlyle did not share, of entering a recessionary environment. Since then, Carlyle have seen clear signs of stabilization in the global economy and continued growth in our portfolio companies. The easing of trade tensions should provide further support in 2020. As everyone here knows, the emerging economic risk is coronavirus. The impact of which we are closely monitoring across our global footprint, while early our view is that this is likely to flatten or postpone, but not reverse the pickup we expected this year. That said, we expect impacts from coronavirus on our portfolio will be relatively limited due to our strong overweight and non-cyclical domestic demand driven activities. All in all, we judge the current environment to be supportive of the continued performance of CGBD’s portfolio. Meanwhile, levered corporate credit markets are currently experiencing a period of strong technical demand. As fixed income asset classes suffer yield compression alongside rates markets. The dislocated conditions and traditional leverage finance markets of the fall of 2019 feel like a distant memory, and repricing activity has been heavy over the past several months. In private credit markets, where nearly all of our investing is conducted, competition remains stiff, putting a premium on breadth and quality of one’s direct origination footprint. Our broad platform positions us well in this respect, and we are able to generate attractive investments across market cycles. Regardless, this is a moment for relative caution, as the relationship between financing execution outcomes and quality of underlying investment is tight. Turning to credit. Over the last 12 months, credit migration has been a detractor from our results. And in our opinion, the principle driver of our otherwise unwarranted discounted valuation relative to book value. We have not been pleased, and our team has been actively working on strategic initiatives to improve credit performance as well as tactical actions to maximize value at position level. Due to those efforts, we’ve reported strong results this quarter. With NAV up, excluding special dividends. Importantly, we stand here today more confident, we will deliver go forward performance in line with our investors and our own expectations. There are 3 reasons for that increased confidence. First, our losses have been highly concentrated in a single strategy exposure, the Carlyle Unitranche Program, otherwise known as CUP. As a result of our efforts and market activity, CUP is now largely exited. To refresh, CUP was an origination partnership we ran from 2015 to 2017, where CGBD took last-out exposure and unitranche financings offer the small borrowers. Since our IPO, CUP has generated over half of CGBD’s net realized and unrealized losses, and nearly 2/3rds of the same figure in the last 12 months, despite representing only 8% of our portfolio. We have now reduced CUP exposure to a single sub-1% position. Further, this position which had been on our watch list, it was recently upgraded as a result of improved performance. CUP can no longer produce the outsized negative results which weighed on our performance in the past. Second, as we analyze prospects for our portfolios performance away from CUP, we take comfort from the structural positioning of our investments. We run a senior heavy portfolio with historically around 70% of assets in true first dollar risk positions. This allows us to exert more control on workouts, experienced less ongoing volatility and sustained less permanent earnings erosion in the case of losses. Consequentially, essentially all of the fair value of our watch list credits today our first dollar exposures, limiting the prospect of more of the high severity outcomes, which characterized our weak credit performance in recent periods. Dermatology Associates, our recent addition to our non-accrual list is in this first dollar category, and there is a name from which we ultimately expect to receive significant recoveries and restore income generation to CGBD. So, while we are by no means immune to future credit losses, the first dollar orientation of our portfolio and watch list leaves us better position to perform going forward. And third, where we do have junior debt exposure, namely the 11% of our portfolio in second lien instruments. We are comfortable with our risk position and track record. We focused our second lien investing on larger borrowers, currently averaging over $100 million of EBITDA. This compares to an average EBITDA of $20 million for the CUP program. For obvious reasons, larger borrowers make for sounder credit profiles. And we have benefitted from an exceedingly strong track record in true second lien investing with positive realized and unrealized performance since inception for CGBD in these loans. Shifting from credits income generation, we should expect us to replace legacy CUP exposures with the combination of large borrower second lien, which we are well positioned to source and an increasingly privately placed market, and additive yield enhancing strategies offered by the Carlyle platform such as our ABL business, which generate on average 150 to 200 basis points of incremental spread as compared to our overall portfolio. By integrating these capabilities, we have the opportunity to concurrently drive incremental yield and diversify our risk factors. In the fourth quarter, we had significant success doing exactly this. Sourcing from Europe to compelling second lien opportunities that are expected to close in the first quarter. These and other recently made investments will significantly offset the temporary yield compression experienced in Q4 from CUP exits. To conclude, our initiatives of the last 9 months to improve portfolio performance are off to a strong start. With these efforts and CUP effectively behind us, we are confident in our ability to deliver improved performance and continue to meet our core investment objective, the delivery of sustainable yield to our shareholders. I’ll now turn the call over to our Chief Financial Officer, Tom Hennigan.